Thirumalai Chem.

  • Market Cap: Small Cap
  • Industry: Commodity Chemicals
  • ISIN: INE338A01024
  • NSEID: TIRUMALCHM
  • BSEID: 500412
INR
176.20
4.5 (2.62%)
BSENSE

Jun 15, 01:57 PM

BSE+NSE Vol: 2.51 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.51 lacs (122.57%) Volume

Shareholding (Mar 2026)

FII

2.06%

Held by 43 FIIs

DII

9.93%

Held by 11 DIIs

Promoter

37.13%

Why is Thirumalai Chemicals Ltd falling/rising?

15-Jun-2026

As of 14-Jun, Thirumalai Chemicals Ltd's stock price has risen to Rs 171.70, reflecting a 5.14% increase after two days of decline. However, the stock has significant long-term underperformance and financial challenges, indicating that the recent rise may be temporary.

As of 14-Jun, Thirumalai Chemicals Ltd is experiencing a rise in its stock price, currently at Rs 171.70, reflecting an increase of Rs 8.4 or 5.14%. This upward movement comes after two consecutive days of decline, indicating a potential trend reversal. The stock has outperformed its sector by 2.78% today and reached an intraday high of Rs 173, which is a 5.94% increase.<BR><BR>Despite this short-term rise, the stock has shown significant underperformance over longer periods, with a year-to-date decline of 27.25% and a one-year drop of 38.85%. The stock is currently trading below its moving averages across various time frames, suggesting a generally bearish trend. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 32.68% compared to the five-day average.<BR><BR>On a positive note, there has been an increase in institutional investor participation, with a 0.56% rise in their stake over the previous quarter. This could indicate a level of confidence from more sophisticated investors, although the overall financial health of the company remains concerning. The company has reported weak long-term fundamentals, including a negative EBITDA and a high Debt to EBITDA ratio, which raises questions about its ability to sustain growth.<BR><BR>In summary, while Thirumalai Chemicals Ltd is currently experiencing a rise in stock price, the broader context of its long-term performance and financial challenges suggests that this increase may be temporary amidst ongoing concerns about its fundamental strength.

View full answer

How big is Thirumalai Chem.?

11-Jun-2026

As of 10th June, Thirumalai Chemicals Ltd has a market capitalization of 2,078.00 Cr, with recent net sales of 1,735.52 Cr and a net loss of 167.91 Cr over the last four quarters.

As of 10th June, <BR><BR>Market Cap: Thirumalai Chemicals Ltd has a market capitalization of 2,078.00 Cr, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 1,735.52 Cr, while the sum of Net Profit for the same period shows a loss of 167.91 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the balance sheet is March 2025. Shareholder's Funds are valued at 1,155.67 Cr, and Total Assets amount to 3,806.75 Cr.

View full answer

Who are in the management team of Thirumalai Chem.?

11-Jun-2026

The management team of Thirumalai Chemicals includes R Parthasarathy (Chairman & Managing Director), Ramya Bharathram (Managing Director & CFO), and several independent and non-executive directors, bringing diverse expertise to the company.

The management team of Thirumalai Chemicals includes the following individuals:<BR><BR>1. R Parthasarathy - Chairman & Managing Director<BR>2. Ramya Bharathram - Managing Director & CFO<BR>3. T Rajagopalan - Company Secretary & Compliance Officer<BR>4. R Sampath - Non-Executive Director<BR>5. P Mohanachandra Nair - Non-Executive Director<BR>6. Raj Kataria - Independent Director<BR>7. Ravi Shankar - Independent Director<BR>8. Dhruv Moondhra - Independent Director<BR>9. Arun Ramanathan - Independent Director<BR>10. Rajeev M Pandia - Independent Director<BR>11. Bhama Krishnamurthy - Independent Director<BR>12. Arun Alagappan - Independent Director<BR><BR>This diverse team brings a range of expertise and leadership to the company.

View full answer

Who are the peers of the Thirumalai Chem.?

11-Jun-2026

Thirumalai Chem.'s peers include GHCL, Tanfac Inds., Grauer & Weil, Chemplast Sanmar, Fischer Medical, J.G.Chemicals, I G Petrochems, TGV Sraac, and Andhra Sugars. In terms of management risk, growth, and capital structure, Thirumalai Chem. is rated average, with a 1-year return of -41.82%.

Peers: The peers of Thirumalai Chem. are GHCL, Tanfac Inds., Grauer & Weil, Chemplast Sanmar, Fischer Medical, J.G.Chemicals, I G Petrochems, TGV Sraac, and Andhra Sugars.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL and J.G.Chemicals, while Average management risk is found at Tanfac Inds., Grauer & Weil, Chemplast Sanmar, I G Petrochems, TGV Sraac, and Thirumalai Chem. Below Average management risk is noted for Fischer Medical and Andhra Sugars. Growth is Excellent at Fischer Medical, Good at Tanfac Inds. and J.G.Chemicals, while Below Average growth is seen at GHCL, Grauer & Weil, Chemplast Sanmar, Thirumalai Chem., I G Petrochems, TGV Sraac, and Andhra Sugars. Capital Structure is Excellent for GHCL, Tanfac Inds., J.G.Chemicals, and I G Petrochems, while Good capital structure is found at Fischer Medical and TGV Sraac, and Below Average at Chemplast Sanmar, Thirumalai Chem., and Andhra Sugars.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Tanfac Inds. at 20.11%, while the lowest is Fischer Medical at -61.28%. Thirumalai Chem.'s 1-year return is -41.82%, which is better than Fischer Medical but worse than Tanfac Inds. Additionally, GHCL, Chemplast Sanmar, Fischer Medical, and Andhra Sugars all have negative six-month returns.

View full answer

What does Thirumalai Chem. do?

10-Jun-2026

Thirumalai Chemicals Ltd is a small-cap company established in 1972, specializing in the manufacturing and marketing of chemical products. As of March 2026, it reported net sales of ₹424 Cr and a net loss of ₹28 Cr, with a market cap of ₹2,078 Cr.

Overview: <BR>Thirumalai Chemicals Ltd is a small-cap company in the commodity chemicals industry, specializing in the manufacturing and marketing of various chemical products.<BR><BR>History: <BR>Incorporated in 1972, Thirumalai Chemicals Limited (TCL) has been engaged in the chemical manufacturing sector since its inception. The latest quarterly results reported net sales and profit for the period ending March 2026.<BR><BR>Financial Snapshot: <BR>- Net Sales: 424 Cr (Quarterly Results - Mar 2026) <BR>- Net Profit: -28 Cr (Quarterly Results - Mar 2026) <BR>- Market Cap: INR 2,078 Cr (Small Cap) <BR><BR>Key Metrics: <BR>- P/E: N/A <BR>- Industry P/E: 42 <BR>- Dividend Yield: 0.00% <BR>- Debt-Equity: 1.22 <BR>- Return on Equity: -10.23% <BR>- Price to Book: 1.34 <BR><BR>Contact Details: <BR>Address: Thirumalai House Road No 29, Nr Sion Hill Fort Sion (East) Mumbai Maharashtra : 400022 <BR>Tel: 91-22-24017841/43686225/43686200 <BR>Email: thirumalai@thirumalaichemicals.com <BR>Website: http://www.thirumalaichemicals.com

View full answer

Should I buy, sell or hold Thirumalai Chemicals Ltd?

02-Jun-2026

Are Thirumalai Chemicals Ltd latest results good or bad?

01-Jun-2026

Thirumalai Chemicals Ltd's latest Q4 FY26 results are concerning, showing a net profit loss of -₹28.00 crores and an 18.89% decline in revenue year-over-year, despite a year-on-year profit improvement. The company's deteriorating operating margin and high debt-to-equity ratio indicate significant financial and operational challenges.

Thirumalai Chemicals Ltd's latest results for Q4 FY26 indicate a challenging financial situation. The company reported a net profit of -₹28.00 crores, which reflects a significant decline of 39.88% compared to the previous quarter, although it shows a year-on-year improvement of 99.15%. However, the overall context is concerning, as the revenue for the quarter was ₹424.25 crores, marking an 18.89% decrease from the same quarter last year, despite a slight quarter-on-quarter increase of 2.02%.<BR><BR>The operating margin has also deteriorated, standing at just 1.45%, down from 2.84% in Q4 FY25. This indicates ongoing operational challenges, including rising input costs and pricing pressures. Additionally, the company's debt-to-equity ratio is at 1.12x, raising concerns about its financial sustainability given the high leverage.<BR><BR>Overall, the results suggest that Thirumalai Chemicals is facing significant operational and financial headwinds, making the latest performance more negative than positive. The combination of persistent losses, declining revenues, and high debt levels paints a troubling picture for the company's future.

View full answer

When is the next results date for Thirumalai Chemicals Ltd?

27-May-2026

The next results date for Thirumalai Chemicals Ltd is 30 May 2026.

The next results date for Thirumalai Chemicals Ltd is scheduled for 30 May 2026.

View full answer

Is Thirumalai Chem. technically bullish or bearish?

05-Dec-2025

As of December 4, 2025, Thirumalai Chem. has shifted to a bearish trend, indicated by a bearish MACD, Bollinger Bands, moving averages, and underperformance against the Sensex.

As of 4 December 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance for Thirumalai Chem. is bearish with a strong indication of weakness. Key indicators driving this stance include a bearish MACD on the weekly chart, bearish Bollinger Bands on both weekly and monthly time frames, and bearish moving averages on the daily chart. Additionally, the KST and Dow Theory are both indicating bearish trends on the weekly level. The stock has underperformed significantly against the Sensex over multiple time frames, further supporting the bearish outlook.

View full answer

How has been the historical performance of Thirumalai Chem.?

09-Nov-2025

Thirumalai Chem. has shown fluctuating financial performance, with net sales decreasing from 2,083.13 Cr in Mar'24 to 2,049.51 Cr in Mar'25, and a decline in profitability, resulting in a profit after tax of -46.10 Cr in Mar'25. The company also faced increasing liabilities and negative cash flow from operating activities.

Answer:<BR>The historical performance of Thirumalai Chem. shows a fluctuating trend in key financial metrics over the years, with significant changes in revenue and profitability.<BR><BR>Breakdown:<BR>Thirumalai Chem. reported net sales of 2,049.51 Cr in Mar'25, a slight decrease from 2,083.13 Cr in Mar'24 and 2,132.24 Cr in Mar'23, but an increase from 1,998.19 Cr in Mar'22. The total operating income mirrored this trend, reaching 2,049.51 Cr in Mar'25. The company's total expenditure, excluding depreciation, was 2,000.71 Cr in Mar'25, down from 2,032.11 Cr in Mar'24, with raw material costs peaking at 1,552.78 Cr in Mar'25. Operating profit (PBDIT) fell to 69.40 Cr in Mar'25 from 70.36 Cr in Mar'24, while profit before tax turned negative at -40.85 Cr in Mar'25 compared to -34.55 Cr in Mar'24. Consequently, the profit after tax also declined to -46.10 Cr in Mar'25 from -38.79 Cr in Mar'24. The company's total assets increased to 3,806.75 Cr in Mar'25 from 3,320.27 Cr in Mar'24, driven by a rise in long-term borrowings to 1,400.66 Cr. Cash flow from operating activities showed a negative trend, recording -65.00 Cr in Mar'25, down from 237.00 Cr in Mar'24, leading to a net cash outflow of -222.00 Cr in Mar'25. Overall, Thirumalai Chem. has experienced a challenging financial landscape, marked by declining profitability and increasing liabilities.

View full answer

Is Thirumalai Chem. overvalued or undervalued?

09-Jun-2025

As of February 7, 2024, Thirumalai Chemicals is considered overvalued with a risky valuation grade, reflected by a PE ratio of -60.28 and an EV to EBITDA of 86.21, while its stock has underperformed the Sensex year-to-date but shows significant long-term gains of 506.69%.

As of 7 February 2024, the valuation grade for Thirumalai Chemicals has moved from very expensive to risky. The company is currently assessed as overvalued. Key ratios indicate significant concerns, with a PE ratio of -60.28, an EV to EBITDA of 86.21, and a ROE of -3.99%. <BR><BR>In comparison to its peers, Thirumalai Chem. stands out negatively; for instance, Solar Industries has a PE ratio of 123.77, while Godrej Industries shows a more favorable PE of 46.63. The substantial divergence in these ratios highlights Thirumalai's challenging position within the commodity chemicals sector. Notably, while Thirumalai's stock has underperformed the Sensex year-to-date with a return of -15.27% compared to the Sensex's 5.66%, its long-term performance over five years shows a remarkable gain of 506.69%, suggesting potential for recovery if operational issues are addressed.

View full answer

Who are the top shareholders of the Thirumalai Chem.?

06-Jun-2025

The top shareholders of Thirumalai Chem. include Ultramarine And Pigments Ltd at 19.97%, individual investors with 44.83%, and the highest public shareholder, Shivani Tejas Trivedi, at 3.65%. Additionally, 51 Foreign Institutional Investors hold 1.97%, and 6 mutual fund schemes account for 0.72% of the shares, with no pledged promoter holdings reported.

The top shareholders of Thirumalai Chem. include Ultramarine And Pigments Ltd, which holds the largest stake at 19.97%. Following that, individual investors collectively own 44.83% of the shares. The highest public shareholder is Shivani Tejas Trivedi, with a holding of 3.65%. Additionally, the company has 51 Foreign Institutional Investors (FIIs) holding 1.97% and 6 mutual fund schemes that account for 0.72% of the shares. There are no pledged promoter holdings reported.

View full answer

Has Thirumalai Chem. declared dividend?

06-Jun-2025

Yes, Thirumalai Chemicals Ltd has declared a 100% dividend, amounting to ₹1 per share, with an ex-date of July 16, 2024. The dividend yield is 0.37%, and total returns have varied across periods, showing significant growth over the last 5 years.

Thirumalai Chemicals Ltd has declared a 100% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 100%<BR>- Amount per share: 1 per share<BR>- Ex-date: 16 Jul 24<BR><BR>Dividend Yield: 0.37%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -29.55%, with a dividend return of 0%, resulting in a total return of -29.55%.<BR><BR>Over the past year, the price return was 4.74%, the dividend return was 0.35%, leading to a total return of 5.09%.<BR><BR>In the last 2 years, the price return was 41.29%, with a dividend return of 1.28%, culminating in a total return of 42.57%.<BR><BR>For the 3-year period, the price return was 4.34%, the dividend return was 2.10%, resulting in a total return of 6.44%.<BR><BR>In the 4-year span, the price return was 102.08%, with a dividend return of 3.73%, leading to a total return of 105.81%.<BR><BR>Over the last 5 years, the price return was 514.71%, and the dividend return was 10.06%, resulting in a total return of 524.77%.<BR><BR>Overall, Thirumalai Chemicals Ltd has declared a significant dividend, which is reflected in the dividend yield. The total returns over various periods show a mixed performance, with notable growth over the longer term, particularly in the 5-year period.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Weak Long Term Fundamental Strength with a -194.41% CAGR growth in Operating Profits over the last 5 years

  • Low ability to service debt as the company has a high Debt to EBITDA ratio of -55.32 times
  • The company has been able to generate a Return on Equity (avg) of 6.69% signifying low profitability per unit of shareholders funds
2

Flat results in Mar 26

3

Risky - Negative EBITDA

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Commodity Chemicals

stock-summary
Market cap

INR 2,124 Cr (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

42

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.22

stock-summary
Return on Equity

-10.23%

stock-summary
Price to Book

1.32

Revenue and Profits:
Net Sales:
424 Cr
(Quarterly Results - Mar 2026)
Net Profit:
-28 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
4.66%
0%
4.66%
6 Months
-25.84%
0%
-25.84%
1 Year
-36.36%
0%
-36.36%
2 Years
-42.68%
0.33%
-42.35%
3 Years
-8.16%
1.26%
-6.9%
4 Years
-24.07%
2.00%
-22.07%
5 Years
24.0%
3.14%
27.14%

Latest dividend: 1 per share ex-dividend date: Jul-16-2024

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Thirumalai Chemicals Drops 15.02%: 6 Key Factors Behind the Steep Decline

Announcements stock-summary

Shareholder Meeting / Postal Ballot-Scrutinizers Report

13-Jun-2026 | Source : BSE

Please find attached Scrutinizers report for the resolution passed by way of postal ballot on Friday June 12 2026.

Announcement under Regulation 30 (LODR)-Credit Rating

10-Jun-2026 | Source : BSE

Intimation of Credit Rating received from ICRA Limited

Announcement under Regulation 30 (LODR)-Newspaper Publication

02-Jun-2026 | Source : BSE

Please find attached newspaper publication by the Company regarding Audited Financial Results for the quarter and year ended March 31 2026

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Thirumalai Chemicals Ltd has declared 100% dividend, ex-date: 16 Jul 24

stock-summary
SPLITS

Thirumalai Chemicals Ltd has announced 1:1 stock split, ex-date: 14 Aug 18

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
9.84%
EBIT Growth (5y)
-194.41%
EBIT to Interest (avg)
4.19
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
1.22
Sales to Capital Employed (avg)
1.02
Tax Ratio
16.79%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.00%
ROCE (avg)
16.80%
ROE (avg)
6.69%

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
42
Price to Book Value
1.32
EV to EBIT
-31.11
EV to EBITDA
-101.05
EV to Capital Employed
1.14
EV to Sales
2.29
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-3.67%
ROE (Latest)
-10.23%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 3 Schemes (8.91%)

FIIs

Held by 43 FIIs (2.06%)

Promoter with highest holding

Ultramarine And Pigments Ltd (18.23%)

Highest Public shareholder

Motilal Oswal Small Cap Fund (7.05%)

Individual Investors Holdings

38.93%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 2.02% vs -6.63% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 39.88% vs -39.51% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "424.25",
          "val2": "415.85",
          "chgp": "2.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6.17",
          "val2": "-15.09",
          "chgp": "140.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "23.60",
          "val2": "21.49",
          "chgp": "9.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-7.98",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-28.00",
          "val2": "-46.57",
          "chgp": "39.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "1.45%",
          "val2": "-3.63%",
          "chgp": "5.08%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -17.08% vs 1.42% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -1,035.27% vs 114.62% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "895.42",
          "val2": "1,079.80",
          "chgp": "-17.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-26.46",
          "val2": "54.19",
          "chgp": "-148.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "43.91",
          "val2": "19.53",
          "chgp": "124.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-93.34",
          "val2": "9.98",
          "chgp": "-1,035.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2.96%",
          "val2": "5.02%",
          "chgp": "-7.98%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -14.10% vs -1.94% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -336.67% vs -74.89% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,311.27",
          "val2": "1,526.45",
          "chgp": "-14.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-41.55",
          "val2": "33.97",
          "chgp": "-222.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "65.40",
          "val2": "33.88",
          "chgp": "93.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-139.91",
          "val2": "-32.04",
          "chgp": "-336.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3.17%",
          "val2": "2.23%",
          "chgp": "-5.40%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is -15.32% vs -1.61% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -264.23% vs -18.85% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,735.52",
          "val2": "2,049.51",
          "chgp": "-15.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-35.16",
          "val2": "48.80",
          "chgp": "-172.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "89.00",
          "val2": "49.15",
          "chgp": "81.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-7.98",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-167.91",
          "val2": "-46.10",
          "chgp": "-264.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2.03%",
          "val2": "2.38%",
          "chgp": "-4.41%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQstock-summary

Mar'26
Dec'25
Change(%)
Net Sales
424.25
415.85
2.02%
Operating Profit (PBDIT) excl Other Income
6.17
-15.09
140.89%
Interest
23.60
21.49
9.82%
Exceptional Items
-7.98
0.00
Consolidate Net Profit
-28.00
-46.57
39.88%
Operating Profit Margin (Excl OI)
1.45%
-3.63%
5.08%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is 2.02% vs -6.63% in Dec 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 39.88% vs -39.51% in Dec 2025

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
895.42
1,079.80
-17.08%
Operating Profit (PBDIT) excl Other Income
-26.46
54.19
-148.83%
Interest
43.91
19.53
124.83%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-93.34
9.98
-1,035.27%
Operating Profit Margin (Excl OI)
-2.96%
5.02%
-7.98%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -17.08% vs 1.42% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is -1,035.27% vs 114.62% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
1,311.27
1,526.45
-14.10%
Operating Profit (PBDIT) excl Other Income
-41.55
33.97
-222.31%
Interest
65.40
33.88
93.03%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-139.91
-32.04
-336.67%
Operating Profit Margin (Excl OI)
-3.17%
2.23%
-5.40%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is -14.10% vs -1.94% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is -336.67% vs -74.89% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
1,735.52
2,049.51
-15.32%
Operating Profit (PBDIT) excl Other Income
-35.16
48.80
-172.05%
Interest
89.00
49.15
81.08%
Exceptional Items
-7.98
0.00
Consolidate Net Profit
-167.91
-46.10
-264.23%
Operating Profit Margin (Excl OI)
-2.03%
2.38%
-4.41%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is -15.32% vs -1.61% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is -264.23% vs -18.85% in Mar 2025

stock-summaryCompany CV
About Thirumalai Chemicals Ltd stock-summary
stock-summary
Thirumalai Chemicals Ltd
Small Cap
Commodity Chemicals
Incorporated in 1972, Thirumalai Chemicals Limited (TCL) was promoted by V S Sundararajan and N R Swamy, Promoter of Ultra Marine & Pigments. It manufactures and markets Phthalic Anhydride, Maleic Anhydride, Tartaric Acid and its salts, Fumaric Acid and Maleic Acid. The Company's principal activities are manufacturing and selling chemicals. The Company manufactures food acids, through which the commercial production commenced since 1992.
Company Coordinates stock-summary
Company Details
Thirumalai House Road No 29, Nr Sion Hill Fort Sion (East) Mumbai Maharashtra : 400022
stock-summary
Tel: 91-22-24017841/43686225/43686200
stock-summary
thirumalai@thirumalaichemicals.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai